{"id":"tp-58866","type":"article-newspaper","title":"Ideaya Plans IDE849 Cohort for About 90 Patients With Neuroendocrine Cancer","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58866","datePublished":"2026-11-16T22:19:25.000Z","dateModified":"2026-11-16T22:19:25.000Z","language":"en","abstract":"The planned single-arm extension would enroll previously treated patients with gastroenteropancreatic neuroendocrine carcinoma in an ongoing Phase 1/2 study.","section":"Business","references":[]}